Investing in Biotech

Randal Kirk, one of the only billionaires to make his money from investing in biotech, says his new synthetic biology company, Intrexon, will be the biggest thing he has ever done, says Forbes' Robert Langreth and Matthew Herper. The company is working on protein-based drugs, gene therapy, industrial enzymes, and ag-bio.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.